Drug Trial Radar · NCT00790998
Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection
Last checked: Nov 19, 2026Latest source record: Jan 31, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,497
Actual
Start
Apr 2009
Primary completion
Feb 2012
Study completion May 2012
Sponsor
- Lead sponsor
- Medicines Development for Global HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- World Health Organization
- First posted
- Nov 14, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3 study comparing the efficacy, safety and tolerability of moxidectin and ivermectin in subjects infected with Onchocerca volvulus, which is the parasite that causes river blindness. Subjects participating in the study will be randomly assigned (by a 2 to1 ratio) to receive one orally-administered dose of either moxidectin or ivermectin.
Conditions
- Onchocerciasis
Interventions
MoxidectinDrug
Single dose of moxidectin 2 mg oral tablet x 4
IvermectinDrug
Single dose of ivermectin 3 mg oral tablet x 2, 3 or 4
Primary outcomes
What the sponsor says the trial is designed to measure.
- skin microfilaria density (mf/mg)Time frame: 12 months
Locations
4 sites in 3 countries. Site status is shown where the registry gives one.
Centre de Recherche Clinique de Butembo - Université Catholique du Graben
Butembo, Democratic Republic of the Congo
Centre de Recherche en Maladies Tropicales de l'Ituri
Rethy, Democratic Republic of the Congo
Onchocerciasis Chemotherapy Research Center
Hohoe, Ghana
Liberian Institute for Biomedical Research Clinical Research Center
Bolahun, Lofa County, Liberia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.